Supramolecular Chemistry in Biological ImagingIn Vivo

Abstract

Biological imaging techniques, including magnetic resonance, optical, nuclear, and ultrasound, can be valuable tools for noninvasively studying biochemical processes at the molecular level. This branch of imaging is referred to as molecular imaging. A main challenge in the field of in vivo molecular imaging is that existing probes limit clinical applications because of their inadequate sensitivity, specificity, and targeting efficiency. Supramolecular chemistry may provide a viable solution to some of these issues. Supramolecular chemical processes involve molecular components assembled into a single, large entity via noncovalent intermolecular forces. The supramolecular concepts of host–guest interaction and self‐assembly have been widely used in the development of more specialized imaging probes for in vivo imaging. This chapter discusses how supramolecular chemistry has been used to design contrast agents with improved signal amplification and specificity for each of the different imaging modalities. Particular attention is focused on magnetic resonance imaging (MRI). Multimodal probes that have benefited from supramolecular chemistry are discussed.

Molecular Imaging of Pancreatic Cancer with Antibodies

“…MRI has several advantages including its unlimited depth penetration, high spatial resolution, and excellent soft tissue contrast, and it does not require radioactive exposure . While a useful imaging modality, MRI suffers from poor sensitivity and long acquisition times. − Next, optical imaging has become widely available in many research institutes in the past decade, yet the clinical translation remains uncertain at present.…”

PET imaging with multimodal upconversion nanoparticles

“…Within molecular imaging, an aspect that is gaining increasing attention is the integration of two or more imaging modalities into a single probe. [1][2][3][4] Motivation for this research interest comes from the fact that the performance of individual imaging modalities is often not completely satisfactory. For example, magnetic resonance imaging (MRI) gives good spatial resolution but its sensitivity is low; positron emission tomography (PET) and single-photon emission computed tomography (SPECT) have excellent sensitivity, but resolution can be an issue; optical imaging has great sensitivity and ex vivo resolution, but in vivo studies can present problems with tissue penetration and resolution.…”